Souhaitez-vous accéder aux communiqués récents ?

Arlington, VA, April 15, 2026 (GLOBE NEWSWIRE) -- Inspire, the world’s largest online community for patients and caregivers, today announced it has been named an Honoree in the 30th Annual Webby...

OAKLAND, Calif., April 15, 2026 (GLOBE NEWSWIRE) -- The Purchaser Business Group on Health (PBGH)—a nonprofit coalition of 40 of the largest public and private health care purchasers in the...

Folia Health's fully remote, app-based study sponsored by Soleno Therapeutics follows PWS caregivers over six months to capture their daily experiences.

Adare Partnership Provides Supply Chain Redundancy and U.S.-based Manufacturing Capability Company Reiterates Guidance - If Approved, Cytisinicline Commercial Launch Expected in First Half of 2027 ...

Study in a well-accepted mouse model of severe Tuberous Sclerosis Complex (TSC) showed that simufilam attenuated the progression of seizures in a dose-dependent mannerResults confirm and extend...

For people living with schizophrenia who may find daily disease management overwhelming due to fragmented support and resources, Home Ground™ Schizophrenia Community is a centralized destination that...

Boehringer Ingelheim and Zai Lab launch a clinical collaboration to evaluate a dual DLL3‑targeting combination therapy in small cell lung cancer (SCLC) and other neuroendocrine carcinomas (NECs).  ...

HEALTHCARE/AI FUNDING NEWS: ONTO Health, an AI-enabled, physician-led fertility and longevity provider, has announced the close of a $20 million Series.

A new white paper has been released which heralds the dawn of a new era of treatment for knee osteoarthritis

Phase 3 trial evaluated two subcutaneous BRIUMVI dosing regimens; administration every 2 months or every 3 months Top-line data expected year-end 2026/ first quarter 2027 NEW YORK, April 15, 2026 ...